BE836390A - Antigene de l'hepatite a. - Google Patents

Antigene de l'hepatite a.

Info

Publication number
BE836390A
BE836390A BE162539A BE162539A BE836390A BE 836390 A BE836390 A BE 836390A BE 162539 A BE162539 A BE 162539A BE 162539 A BE162539 A BE 162539A BE 836390 A BE836390 A BE 836390A
Authority
BE
Belgium
Prior art keywords
hepatitis
antigen
Prior art date
Application number
BE162539A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE836390A publication Critical patent/BE836390A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5768—Hepatitis A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE162539A 1974-12-09 1975-12-08 Antigene de l'hepatite a. BE836390A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,623 US4029764A (en) 1974-12-09 1974-12-09 Hepatitis A antigen

Publications (1)

Publication Number Publication Date
BE836390A true BE836390A (fr) 1976-06-08

Family

ID=24114319

Family Applications (1)

Application Number Title Priority Date Filing Date
BE162539A BE836390A (fr) 1974-12-09 1975-12-08 Antigene de l'hepatite a.

Country Status (11)

Country Link
US (1) US4029764A (en:Method)
JP (1) JPS5182720A (en:Method)
BE (1) BE836390A (en:Method)
CY (1) CY1104A (en:Method)
DE (1) DE2555169A1 (en:Method)
FR (1) FR2293944A1 (en:Method)
GB (1) GB1508878A (en:Method)
HK (1) HK4081A (en:Method)
KE (1) KE3110A (en:Method)
MY (1) MY8100308A (en:Method)
NL (1) NL189050C (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296024A (en) * 1974-12-09 1981-10-20 Merck & Co., Inc. Human immune serum globulin with high hepatitis A antibody titer
US4017601A (en) * 1975-10-16 1977-04-12 Merck & Co., Inc. Hepatitis A antigen
JPS5283929A (en) * 1976-01-01 1977-07-13 Merck & Co Inc Hepatisis a antigen
NL7711378A (nl) * 1976-11-02 1978-05-05 Merck & Co Inc Werkwijze voor het bereiden van preparaten die dane-deeltjes bevatten.
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
CA1164799A (en) 1979-09-04 1984-04-03 Paula A. Giesa Cell culture of hepatitis a virus
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
JPS63246335A (ja) * 1987-09-17 1988-10-13 メルク　エンド　カムパニー　インコーポレーテツド 肝炎ｂ抗原
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3735004A (en) * 1971-11-01 1973-05-22 Us Army Hepatitis vaccine
NL189051C (nl) * 1974-12-09 1992-12-16 Merck & Co Inc Werkwijze voor het bepalen van antilichamen in een monster.

Also Published As

Publication number Publication date
MY8100308A (en) 1981-12-31
JPS5182720A (en) 1976-07-20
KE3110A (en) 1981-02-20
US4029764A (en) 1977-06-14
GB1508878A (en) 1978-04-26
JPS6335612B2 (en:Method) 1988-07-15
CY1104A (en) 1981-09-11
HK4081A (en) 1981-02-13
DE2555169C2 (en:Method) 1987-08-13
NL189050C (nl) 1992-12-16
FR2293944A1 (fr) 1976-07-09
DE2555169A1 (de) 1976-06-10
NL7513816A (nl) 1976-06-11
FR2293944B1 (en:Method) 1979-03-02

Similar Documents

Publication Publication Date Title
HU172032B (hu) Sposob poluchenija al'fa-/1-aril-1,2-digidro-2-okso-khinol-4-il/-alkankarbonovykh kislot
TR19047A (tr) 3,5-difenil-4(ih)-piridonlar(tionlar)
JPS57203016A (en) Hepatitis b antigen
HU171875B (hu) Dvigatel' vnutrennego sgoranija s kompressionnym zazhiganiem
BE836390A (fr) Antigene de l'hepatite a.
PT64721B (fr) Incinerateur d'ordures.
NL7704026A (nl) Cycloconvertor.
HU171805B (hu) Sposob poluchenija 1-skobka-p-metilsul'finil-benziliden-skobka zakryta-2-metil-5-ftoro-indenil-3-uksusnojj kisloty
SE7507728L (sv) Forgasare.
BE847343A (fr) Antigene d'hepatite a,
SE412207B (sv) Fodrad forpackning
NL7509616A (nl) "fm-am omzetter".
FR2282069A1 (fr) Moyens d'accouplement
FR2283692A1 (fr) Complexes de 2,4-dioxopyrimidine d'ethylenediamineplatine (ii)
HU171908B (hu) Sposob poluchenija proizvodnykh 5-sul'famoil-antranilovoj kisloty
BE818797A (fr) Antigene de tetanos
HU170811B (hu) Sposob poluchenija slozhnykh efirov 3-cefem-3-sul'fokislot
SE7505858L (sv) Forgasare.
BE831458A (fr) Bis-cyclohexanols 0,0,0',0'-tetralcoyl-substitues
HU173508B (hu) Usovershenstvovannyjj sposob poluchenija al'fa-6-dezoksi-5-gidroksi-tetraciklina
BE852772A (fr) Vide-ordures
NL7514213A (nl) Fotovolgordeprogrammeur.
HU174299B (hu) Sposob poluchenija korma dlja krupnykh skot soderzhahhego frakcii a ili d antibiotika a-28 086, dlja uvelichenija ispol'zovanijy pitatel'nykh vehhestv v skotakh
RO73531A (ro) Procedeu de preparare a 3-beta-(4'-oxo-alfa l-ramnozil)-14 beta-hidroxibufa-4,20,22-trienolidei
BE830890A (fr) Syn-oximes de 1,4-cyclohexadiene-1-carboxaldehyde

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19931231